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S-GH-7
NITRIC OXIDE SYNTHASE (NOS) EXPRESSION AND NITRIC OXIDE (NO) PRODUCTION IN CCL4-INDUCED
HEPATOTOXICITY OF RATS S. Y. Chung1. G. L. Tipoe2, P. C. W. Fung', I. O. L. Ng3, C. L. Lai1 Department of 1Medicine,
2Anatomy and 3Pathology, The University of Hong Kong, Hong Kong, China.
Background. Some chronic liver diseases such as hepatitis B, alcoholic liver diseases can cause liver cirrhosis. Cirrhosis is irreversible
and the liver becomes permanently injured and scarred. Nitric oxide (NO) is an L-arginine derived, short-lived free-radical which is
synthesized by three nitric oxide synthase (NOS) isoforms : constitutive endothelial NOS (eNOS), inducible NOS (iNOS) and neuronal
NOS. NO is highly unstable in oxygenated, aqueous solution and will be oxidized to more stable nitrite (NO2~) and nitrate (NO3). In
normal liver, only eNOS is present and NO produced here is to regulate the hepatic blood flows. Under certain circumstances iNOS
expression is increased. This in turn produces more NO inside the liver.Method. Severe liver damage / cirrhosis is induced in
phenobarbital-primed rats intragastrically (group G) and intraperitoneally (group P) by CC14 together with corn oil (1:1) once weekly
for twelve weeks and twice weekly for eight weeks respectively. Their drinking water was supplemented with phenobarbital sodium
salt (350mg/L) throughout the cirrhosis induction period. A third group of rats, phenobarbital control rats (group C), was given
phenobarbital sodium salts in their drinking water and treated with corn oil. A fourth group of untreated rats was taken as normal
control (group N). Immunocytochemical staining (ICC), electron paramagnetic resonance (EPR) spectroscopy and nitric oxide
analyzer (NOA) using chemiluminescence detection were applied in liver tissues and serum to indicate the relative amount / concentration
of NOS, cyclooxygenase (Coxl and Cox2), NO and NO2 together with NO3 Liver tissues for light microscopy study were stained
with haematoxylin and eosin (H&E) and trichrome. Liver histology was assessed using light microscopy. The degree of liver fibrosis
was classified as grade O (normal liver) - grade 4 (cirrhosis), according to the severity of liver damage (Knodell's scoring system for
fibrosis).Results. All CCl4-treated rats developed hepatotoxicity with at least grade 3 fibrosis.
Group N Group C Group (P + G)
No. of rats used 6 10 20
Mean grade of fibrosis O O 3.7±0.5
EPR intens i ty (cm) 1.35±0.67 ().76±0.15a 0.59±0.22a
NO 2 ' /NO3-conc . (uM) 22.21±4.33 26.86±6.83b 17.97±7.36b
eNOS expression (%area) 5.73±0.26c 5.22±2.13c
iNOS expression (%area) 7.64±0.32d 6.63±2.48d
For a, p =not significant; b, p = 0.008; c, p = not significant; d, p = 0.001
When compared to Group P rats, Group G rats had lower EPR signal intensity (p = 0.0001), NO,/NO, concentration (p = 0.002), eNOS expression (p = 0.03)
and iNOS expression (p =5E-10). Conclusion And Hypothesis. CCI^-induced hepatotoxicity in rats (Group G and Group P rats) reduced NO,/NO, concentration
and iNOS expression, eNOS expression also showed a trend in reduction. We postulate that the reduction in iNOS expression is related to the loss of
detoxification function in endstage liver damage. The trend in reduction of eNOS expression may be the result of damage to the microcirculation.
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LOW DOSE RECOMBINANT HUMAN GROWTH HORMONE IN THE TREATMENT OF
MALNOURISHED ELDERLY PATIENTS.
L.W. Chu, KSL Lam, S Tam, W Hu, SL Hui, A Chiu, P. Ng University Department of Medicine, Department of Dietetics
and Division of Clinical Biochemistry, Queen Mary Hospital, University of Hong Kong, 102 Pokfulam Road, Hong Kong SAR
High dose human growth hormone (rhGH) has been shown to improve nutritional status of malnourished older
adults. It was uncertain whether low dose rhGH was effective and whether its effect on nutritional status would lead
to improvement in physical function. The purpose of the present study was to determine the efficacy of low dose
rhGH in treating malnourished geriatric patients and its effect on the physical function of these patients. Nineteen
stable malnourished geriatric patients were randomized into two groups - low dose rhGH or placebo. Patients with
cancer, infections, untreated depression or other secondary causes for malnutrition were excluded. In the rhGH
group, 0.09 IU/Kg 3 times weekly were given together with appropriate dietary intervention as prescribed by our
dietitian. In the placebo group, equal volume of normal saline 3 times weekly were given together with dietary
intervention. There was no statistically significant difference in baseline demographic, nutritional, IGF-1 and
physical function variables between the two groups. The GH treated group showed a more rapid gain in body
weight, total lean body mass (i.e. +1.41 vs. -0.49 Kg., change in total lean body mass after 3 weeks- by bio-impedance
method; p=0.007, unpaired t-test) and a faster improvement in 5-meter walking time (decrease in 5-m. walking
time 27.45 vs. 0.45 sec. after 4 weeks; p=0.026, unpaired t-test) than the placebo group. The rise in IGF-1 at 4 week
was significantly greater in the GH treated group (i.e. 49.07 vs. 17.52; p=0.04, unpaired t-test). There is no statistically
significant difference for other nutritional variables. Conclusions: In our study, low dose rhGH was an effective
adjuvant therapy for stable malnourished geriatric patient. It led to a faster gain in lean body mass, which was
associated with greater improvement in walking speed when compared with dietary intervention alone.
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